vaxneuvance
merck sharp & dohme b.v. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - sýkingar af völdum pneumókokka - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. sjá kafla 4. 4 og 5. 1 til að fá upplýsingar um vernd gegn tilteknum sermigerðum pneumokokkum. the use of vaxneuvance should be in accordance with official recommendations.
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 500 mg
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 1 g
williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g
meropenem sun stungulyfs-/innrennslisstofn, lausn 1 g
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g
meropenem sun stungulyfs-/innrennslisstofn, lausn 500 mg
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
amoxicillin/clavulanic acid normon stungulyfs-/innrennslisstofn, lausn 1000/200 mg
laboratorios normon s.a. - amoxicillinum natríum; acidum clavulanicum kalíum - stungulyfs-/innrennslisstofn, lausn - 1000/200 mg
cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 1500 mg
fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1500 mg
cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 750 mg
fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg
ceftriaxona normon stungulyfs-/innrennslisstofn og leysir, lausn 1000 mg
laboratorios normon, s.a. - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn og leysir, lausn - 1000 mg
zitromax stofn fyrir innrennslisþykkni, lausn 500 mg
pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg